1. Home
  2. TENX vs TCI Comparison

TENX vs TCI Comparison

Compare TENX & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$15.81

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

N/A

Current Price

$44.10

Market Cap

350.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
TCI
Founded
1967
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
350.0M
IPO Year
2001
1994

Fundamental Metrics

Financial Performance
Metric
TENX
TCI
Price
$15.81
$44.10
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
1.4M
3.2K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
135.29
EPS
N/A
0.02
Revenue
N/A
$49,060,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2,167.00
Revenue Growth
N/A
4.23
52 Week Low
$5.80
$31.48
52 Week High
$19.40
$59.65

Technical Indicators

Market Signals
Indicator
TENX
TCI
Relative Strength Index (RSI) 56.67 52.34
Support Level $12.84 $43.15
Resistance Level $16.35 $45.56
Average True Range (ATR) 1.27 1.77
MACD -0.15 -0.48
Stochastic Oscillator 41.10 15.66

Price Performance

Historical Comparison
TENX
TCI

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates in two business segments: the acquisition, development, ownership and management of multifamily properties; and the acquisition, development, ownership and management of commercial properties; which are office properties. The services for its commercial segment include rental of office space and other tenant services, including parking and storage space rental. The services for its multifamily segment include rental of apartments and other tenant services, including parking and storage space rental. the company derives maximum revenue from Multifamily Segment.

Share on Social Networks: